Physician profile
Alla Fishman
NPI 1285813030
$1,424.17
in general payments reported to CMS, 2019-2025
9 companies · $211 in 2025
The $211 reported for 2025 was more than what 76% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $195 · 2022: $933 · 2023: $57.41 · 2024: $27.77 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $296.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $947.35 | 2022-2024 | Tph Spectra Universal Composite Restorative Low Viscosity |
| A-Dec, INC. | $195.00 | 2021 | |
| Zimvie INC. | $129.03 | 2025 | |
| Shofu Dental Corp | $57.41 | 2023 | |
| Geistlich Pharma, North America, INC. | $28.96 | 2025 | Biomaterials |
| Voco America INC. | $21.24 | 2025 | Meron Plus Qm, Futurabond U, Admira Fusion |
| Orapharma, A Division of Bausch Health US, LLC | $17.52 | 2025 | Arestin |
| Philips North America LLC | $14.24 | 2025 | Cordless Pf Combos |
| Sprintray INC | $13.42 | 2024 | Pro 2 3d Printer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alla Fishman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.